Oliver Lagore Vanvalin Investment Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.14M Buy
+2,298
New +$1.2M 0.45% 55
2024
Q4
$342K Buy
655
+129
+25% +$67.2K 0.09% 99
2024
Q3
$258K Sell
526
-3,905
-88% -$1.82M 0.07% 109
2024
Q2
$1.97M Buy
4,431
+446
+11% +$178K 0.57% 35
2024
Q1
$1.59M Buy
3,985
+291
+8% +$110K 0.47% 45
2023
Q4
$1.25M Buy
3,694
+1,535
+71% +$458K 0.46% 37
2023
Q3
$631K Buy
+2,159
New +$674K 0.25% 64
2022
Q4
Sell
-3
Closed -$1K 720
2022
Q3
$1K Hold
3
﹤0.01% 580
2022
Q2
$1K Buy
+3
New +$704 ﹤0.01% 557

Other funds holding ISRG

Oliver Lagore Vanvalin Investment Group's ISRG Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Intuitive Surgical (ISRG) in Q2 2025: 2,298 shares worth $1.14M. The stake represents 0.45% of the portfolio and ranks #55 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in ISRG as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in ISRG in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.97M in Q2 2024. 2,265 funds tracked by Wall St. Rank hold ISRG as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 2,298 shares of Intuitive Surgical worth $1.14M as of Q2 2025.
  • Intuitive Surgical was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Intuitive Surgical made up 0.45% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #55 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Intuitive Surgical in Q2 2022 and has held it in 9 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Intuitive Surgical position peaked at $1.97M in Q2 2024.
  • 2,265 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.